Sulphur mustard poisoning and its complications in Iranian veterans

Iranian Journal of Medical Sciences

Volumn 34, Issue 3, 2009, Pages 155-171

  Balali Mood, Mahdi ^a   Balali Mood, Beeta ^b  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Chemical warfare agents; Complications; Iranian; Mustard gas; Poisoning; Sulphur mustard; Toxic effects; Veterans

Indexed keywords

METHENAMINE; MUSTARD GAS;

ASTHMA; BRONCHOPNEUMONIA; CARCINOGENICITY; CARDIOTOXICITY; CELL PROTECTION; CHEMICAL WARFARE; CHRONIC BRONCHITIS; CHRONIC DISEASE; CLINICAL FEATURE; DISEASE SEVERITY; DNA SYNTHESIS; DRY SKIN; GAS POISONING; GASTROINTESTINAL TOXICITY; HUMAN; INFECTION RISK; INTOXICATION; LUNG FIBROSIS; LUNG TOXICITY; MENTAL DISEASE; MUTAGENICITY; NEUROLOGIC DISEASE; NONHUMAN; REVIEW; TERATOGENICITY; TOXICOKINETICS; VETERAN; WAR;

EID: 67749088549     PISSN: 02530716     EISSN: 17353688     Source Type: Journal    
DOI: None     Document Type: Review

References (112)

1. Pechura C M, Rall DP. Chemistry of Sulfur Mustard and Lewisite. In: Veterans at Risk: The Health Effects of Mustard Gas and Lewisite, Institute of Medicine, The National Academies Press, Washington D C, USA, 1993. p. 71-80.
2. Sidell F R, Takafuji E T, Franz D R. Vesicants. In: Zajtchuk R, Bellamy RF, eds. Medical aspects of chemical and biological warfare, Published by the Office of The Surgeon General at TMM Publications, Borden Institute, Walter Reed Army Medical Center, Washington, DC, USA, 1997. p. 197-228.
3. Prentiss A.M. Vesicant agents. IN: Chemicals in warfare: a treatise on chemical warfare. McGraw-Hill, New York, USA, 1937. p. 177-300.
4. Balali-Mood M, Hefazi M. The pharmacology, toxicology, and medical treatment of sulphur mustard poisoning. Fundam Clin Pharmacol 2005; 19: 297-315. (Pubitemid 40769451)
5. United Nations Security Council. Report of the mission dispatched by the Secretary General to investigate allegations of the use of chemical weapons in the conflict between the Islamic Republic of Iran and Iraq. S/19823 and S/19823/Addendum 1. United Nations, New York, USA. April 25, 1988.
6. Balali-Mood M, Hefazi M. Comparison of early and late toxic effects of sulfur mustard in Iranian veterans. Basic Clin Pharmacol Toxicol 2006; 99: 273-282 (Pubitemid 44578902)
7. Mandel M, Gibson WS. Clinical manifestations and treatment of mustard gas poisoning. J Am Med Assoc 1917; 69: 1970-1971
8. Balali-Mood M, Hefazi M, Mahmoudi M, et al. Long-term complications of sulphur mustard poisoning in severely intoxicated Iranian veterans. Fundam Clin Pharmacol 2005; 19: 713-721 (Pubitemid 43822007)
9. Hurst CG, Smith WJ. Chronic effects of acute low level exposure to the chemical warfare agent sulphur mustard. In: Somani S M and Romano J A (Eds) Chemical Warfare Agents: Toxicity at Low Levels, CRC Press, London, 2001. p. 245-260
10. Ghanei M, Fathi H, Mohammad MM, et al. Long-term respiratory disorders of claimers with subclinical exposure to chemical warfare agents. Inhal Toxicol 2004; 16: 491-495 (Pubitemid 38923912)
11. Brown EC. Pulmonary effects following chronic exposure to HS vapor. In: Medical Division Report No. 187. U.S. Army Chemical Centre, Washington, DC, USA; 1949. p. 1-31.
12. Nishimoto Y, Burrows B, Miyanishi M, et al. Chronic obstructive lung disease in Japanese poison gas workers. Am Rev Respir Dis 1970; 102: 173-179
13. Hefazi M, Attaran D, Mahmoudi M, Balali- Mood M. Late respiratory complications of mustard gas poisoning in Iranian veterans. Inhal Toxicol 2005, 17: 587-592 (Pubitemid 41161312)
14. Hefazi M, Maleki M, Mahmoudi M, Tabatabaee A, Balali-Mood M. Delayed complications of sulfur mustard poisoning in the skin and the immune system of Iranian veterans 16-20 years after exposure. Int J Dermatol 2006; 45: 1025-1031 (Pubitemid 44317113)
15. Pickard HL. Ocular action of dichloroethyl sulfide (mustard gas). Am J Ophthalmol 1919; 3: 136.
16. Etezad-Razavi M, Mahmoudi M, Hefazi M, Balali-Mood M. Delayed ocular complications of mustard gas poisoning and the relationship with respiratory and cutaneous complications. Clin Experiment Ophthalmol 2006; 34: 342-346 (Pubitemid 44137552)
17. Anslow WP, Houk CR. Systemic pharmacology and pathology of sulfur and nitrogen mustards. In: Anslow WP, Houk CR, eds. Chemical Warfare Agents and Related Chemical Problems. Washington, DC, USA: National Defense Research Committee; 1946. p. 440-478
18. World Health Organization. Health aspects of chemical and biological weapons. World Health Organization, Geneva, Switzerland, 1970.
19. Balali-Mood M, Farhoodi M, Panjvani FK. Report of three fatal cases of war gas poisoning. In: Heyndrickx A, ed. Proceedings of the Second World Congress on New Compounds in Biological and Chemical Warfare. Ghent, Belgium: Rijksuniversiteit, 1986. p. 475-482
20. Balali-Mood M, Navaeian A. Clinical and paraclinical findings in 233 patients with sulfur mustard poisoning. In: Heyndrickx A, ed. Proceedings of the Second World Congress on New Compounds in Biological and Chemical Warfare. Ghent, Belgium: Rijksuniversiteit, 1986, p. 464-473
21. Easton DF, Peto J, Doll R. Cancers of the respiratory tract in mustard gas workers. Br J Ind Med 1988; 45: 652-659 (Pubitemid 18246389)
22. Balali-Mood M. First Report of Delayed toxic effects of Yperite poisoning in Iranian fighters, Proc. Int Assoc Foren Toxicol 1986. p. 474-479
23. Walker IG. Intrastrand bifunctional alkylation of DNA in mammalian cells treated with mustard gas. Can J Biochem 1971; 49: 332-336
24. Ball CR, Roberts JJ. Estimation of interstrand DNA crosslinking resulting from mustard gas alkylation of HeLa cells. Chem Biol Interact 1972; 4: 297-303.
25. Wheeler GP. Studies related to the mechanisms of action of cytotoxic alkylating agents: a review. Cancer Res 1962; 22: 651-688
26. Rankin PW, Jacobson MK, Mitchell VR, Busbee DL. Reduction of nicotinamide adenine dinucleotide levels by ultimate carcinogens in human lymphocytes. Cancer Res 1980; 40: 1803-1807
27. Eklöw L, Moldéus P, Orrenius S. Oxidation of glutathione during hydroperoxide metabolism: a study using isolated hepatocytes and glutathione reductase inhibitor 1, 3-bis(2- chloroethyl)-1-nitrosurea. Eur J Biochem 1984; 138: 459-463 (Pubitemid 14192103)
28. Cullumbine H. Medical aspects of mustard gas poisoning. Nature 1947; 159: 151-153
29. Langenberg JP, van der Schans GP, Spruit H.E, et al. Toxicokinetics of sulphur mustard and its DNA-adducts. Drug Chem Toxicol 1998, 21: 131-147
30. Chilcott RP, Jenner J, Carrick W, et al. Human skin absorption of Bis-2-(chloroethyl) sulphide (sulphur mustard) in vitro. J Appl Toxicol 2000; 20: 349-355
31. Davison C, Rozman RS, Smith PK. Metabolism of bis-beta-chloroethyl sulfide (sulfur mustard gas). Biochem Pharmaco1 1961; 7: 65-74.
32. Kehe K, Szinicz L. Medical aspects of sulphur mustard poisoning. Toxicology 2005; 214: 198-209. (Pubitemid 41406260)
33. Clemedson CJ, Kristoffersson H, Soerbo B, Ullberg S. Whole body autoradiographic studies of the distribution of sulphur 35- labelled mustard gas in mice. Acta Radiol Ther Phys Biol 1963; 1: 314-320
34. Drasch G, Kretschmer G, Kauert L, von Meyer L. Concentration of mustard gas [bis(2-chloroethyl)sulfide] in the tissues of a victim of a vesicant exposure. J Forensic Sci 1987; 32: 1788-1793 (Pubitemid 17167440)
35. Roberts JJ, Warwick GP. Studies of the mode of action of alkylating agents. VI. The metabolism of bis-2-chlorethylsulphide (mustard gas) and related compounds. Biochem Pharmacol 1963; 12: 1329-1334
36. Sasser LB, Cushing JA, Dacre JC. Twogeneration reproduction study of sulfur mustard in rats. Reprod Toxicol 1996; 10: 311-319 (Pubitemid 26310260)
37. Pechuta CM, Rall DP. Relationship of mustard agent and Lewisite exposure to carcinogenesis. In: Pechuta CM, Rall DP, eds. Veterans at Risk, the Health Effects of Mustard Gas and Lewisite. Washington DC, USA: National Academy Press; 1993. p. 81-111.
38. Wada S, Miyanishi M, Nishimoto Y, et al. Mustard gas: a cause of respiratory neoplasia in man. Lancet 1968; 2: 1161-1163
39. Manning KP, Skegg DC, Stell PM, Doll R. Cancer of the larynx and other occupational hazards of mustard gas workers. Clin Otolaryngol 1981; 6: 165-170 (Pubitemid 12198157)
40. Balali-Mood M. Evaluation of late toxic effects of sulfur mustard poisoning in 1428 Iranian veterans. The Seminar on Late Complications of Chemical Warfare Agents in Iranian Veterans. Tehran, Iran: Veteran Foundation; 1992. p. 15-37.
41. Inada S, Hiragun K, Seo K, Yamura T. Multiple Bowen's disease observed in former workers of a poison gas factory in Japan with special references to mustard gas exposure. J Dermatol 1978; 5: 49-60. (Pubitemid 8353847)
42. Graef I, Karnofsky DA, Jaeger V, et al. The clinical and pathologic effects of the nitrogen and sulfur mustards in laboratory animals. Am J Pathol 1948; 24: 1-47.
43. Giraud H. The first symptoms of intoxication from mustard gas. J Med Chir Prat 1917; 88: 890-894
44. Helm UK, Balali-Mood M. Cutaneous lesions produced by sulfur mustard. The First International Medical Congress on Chemical Warfare Agents in Iran. June 13-6, Mashhad, Iran, Mashhad University of Medical Sciences, 1988. p. 90.
45. Papirmeister B, Feister AJ, Robinson SI. Medical Defense against Mustard Gas: Toxic Mechanisms and Pharmacological Implications. Boca Raton, USA: CRC Press; 1991.
46. Canelli AF. Contrbuto alla conoscenza dell' intossicazione acuta da "Yperite" ed in particolare del suo reperto anatomo-patologico. Rivista Ospedaliera Italiana 1918; 8: 2-7.
47. Thomsen AB, Erkisen Y, Smidt-Nielsen K. Chronic neuropathic symptoms after exposure to mustard gas: a long-term investigation. J Am Acad Dermatol 1988, 39: 187-190
48. Willems JL. Clinical management of mustard gas casualties. Ann Med Mil Belg 1989; 3: S1-S61.
49. Balali-Mood M, Tabarestani M, Farhoodi M, Panjvani FK. Study of clinical and laboratory findings of sulfur mustard in 329 war victims. Med J I R 1991; 34: 7-15.
50. Tabarestani M, Balali-Mood M, Farhoodi M. Hematological findings of sulfur mustard poisoning in Iranian combatants. Med J Islam Repub Iran 1990; 4: 185-190
51. Mahmoudi M, Hefazi M, Rastin M, Balali- Mood M. Long-term hematological and immunological complications of sulfur mustard poisoning in Iranian veterans. Int Immunopharmacol 2005; 5: 1479-1485 (Pubitemid 40813304)
52. Tabarestani M, Farhoudi M, Balali-Mood M. Stem cell and erythroid precursors disorders in three patients with sulfur mustard poisoning. The First International Medical Congress on Chemical Warfare Agents in Iran. June 13-16 Mashhad, Iran, Mashhad University of Medical Sciences, 1988 .p. 10.
53. Krumbhaar EB, Krumbhaar HD. The blood and bone marrow in yellow cross gas (mustard gas) poisoning. J Med Res 1919; 40: 497-506.
54. Dayhimi I, Bahar K, Eliasy H. The effect of sulfur mustard gas (SMG) on the immune system. The First International Medical Congress on Chemical Warfare Agents in Iran. June 13-6, Mashhad, Iran: Mashhad University of Medical Sciences; 1988. p. 12.
55. Zandieh T, Marzaban S, Tarabadi F, Ansari H. Defects of cell-mediated immunity in mustard gas injury after years. (Abstract). Scand J Immunol 1990; 32: 423.
56. Ghotbi L, Hassan Z. The immunostatus of natural killer cells in people exposed to sulphur mustard. Int Immunopharmacol 2002; 2: 981-985 (Pubitemid 34756388)
57. Dacre J.C., Goldman M. Toxicology and pharmacology of the chemical warfare agent sulphur mustard. Pharmaco Rev 1996; 48: 289-326. (Pubitemid 26196589)
58. Aghanouri R, Ghanei M, Aslani J, et al. Fibrogenic cytokine levels in bronchoalveolar lavage aspirates 15 years after exposure to sulfur mustard. Am J Physio Lung Cell Mo Physiol 2004; 287: L1160-4. (Pubitemid 39507192)
59. WHO. Health Aspects of Chemical and Biological warfare Agents, world Health Organization, December 2003.
60. Heyndrickx A. Analytical methods for detection and determination of sulphur mustard in environmental and biologicalsamples. In: Heyndrickx B, ed. Proceedings of the Second World Congress on New Compounds in Biological and Chemical Warfare. Ghent, Belgium, Rijksuniversiteit; 1986. p. 112-128
61. Noort D, Benschop HP, Black RM. Biomonitoring of exposure to chemical warfare agents: a review. Toxicol Appl Pharmacol 2002; 184: 116-126 (Pubitemid 35339395)
62. Fidder A, Moes GWH, Scheffer AG, et al. Synthesis, characterization, and quantitation of the major adducts formed between sulfur mustard and DNA of calf thymus and human blood. Chem Res Toxicol 1994; 7: 199-204. (Pubitemid 24105352)
63. van der Schans GP, Scheffer AG, Mars- Groenendijk RH, et al. Immunochemical detection of adducts of sulfur mustard to DNA of calf thymus and human white blood cells. Chem Res Toxicol 1994; 7: 408-413
64. Benschop HP, van der Schans GP, Noort D, et al. Verification of exposure to sulfur mustard in two casualties of the Iran- Iraq conflict. J Anal Toxicol 1997; 21: 249-251 (Pubitemid 27349041)
65. Black RM, Brewsterk K, Clarke RJ, et al. Biological fate of sulfur mustard, 1,1'- thiobis(2-chloroethane): isolation and identification of urinary metabolites following intraperitoneal administration to rat. Xenobiotica 1992, 22: 405-418
66. Fidder A, Noort D, de Jong LP, et al. N7-(2- hydroxyethylthioethyl)- guanine: a novel urinary metabolite following exposure to sulphur mustard. Arch Toxicol 1996; 70: 854-855
67. Black RM, Read RW. Biological fate of sulphur mustard, 1,1'-thiobis(2-chloroethane): identification of beta-lyase metabolites and hydrolysis products in human urine. Xenobiotica 1995; 25: 167-173
68. Wills ERJ, Hulst AJ, De Jong AL, et al. Analysis of thiodiglycol in urine of victims of an alleged attack with mustard gas. J Anal Toxicol 1985; 9: 254-257
69. Wills ER, Hulst AJ, van Laar J. Analysis of thiodiglycol in urine of victims of an alleged attack with mustard gas, part II. J Anal Toxicol 1988; 12: 15-19
70. Black RM, Read RW. Detection of trace levels of thiodiglycol in blood, plasma, and urine using gas chromatography electron capture negative ion chemical ionization mass spectrometry. J Chromatogr 1988; 449: 261-270 (Pubitemid 18245070)
71. Black RM, Read RW. Improved methodology for the detection and quantitation of Urinary metabolites of sulfur mustard using gas chromatography tandem mass spectrometry. J Chromatogr Biomed Appl 1995; 665: 97-105.
72. Sulzberger MB, Katz JH. The absence of skin irritants in the contents of vesicles. US Navy Med Bull 1943, 43: 1258-1262
73. Black RM, Clarke RJ, Harrison JM, Read RW. Biological fate of sulphur mustard: identification of valine and histidine adducts in haemoglobin from casualties of sulphur mustard poisoning. Xenobiotica 1997; 27: 499-512.
74. Ghanei M, Adibi I. Clinical review of mustard lung. Iran J Med Sci 2007; 32: 58-65.
75. Khateri Sh, Ghanei M, Keshavarz S, et al. Incidence of lung, eye and skin lesions as late complications in 34,000 Iranian with wartime exposure to mustard agent. J Occup Environ Med 2003; 45: 1136-1143 (Pubitemid 37420858)
76. Bagheri MH, Hosseini SK, Mostafavi SH, Alavi SA. High-resolution CT in chronic pulmonary changes after mustard gas exposure. Acta Radiol 2003; 44: 241-245
77. Bakhtavar K, Sedighi N, Moradi Z. Inspiratory and Expiratory High-Resolution Computed Tomography (HRCT) in Patients with Chemical Warfare Agents Exposure. Inhal Toxicol 2008; 20: 507-511
78. Emad A, Rezaian GR. The diversity of effects of sulfur mustard gas inhalation on respiratory system 10 years after a single heavy exposure: analysis of 197 cases. Chest 1997; 112: 734-738 (Pubitemid 27410711)
79. Ghanei M, Hosseini A R, Arabbaferani Z, Shahkarami E. Evaluation of chronic cough in chemical chronic bronchitis patients. Environ Toxicol Pharmacol 2005; 20: 6-10. (Pubitemid 40615350)
80. Ghanei M, Khedmat H, Mardi F, Hosseini A. Distal esophagitis in patients with mustard-gas induced chronic cough. Dis Esophagus 2006; 19: 285-288 (Pubitemid 44027093)
81. Ghanei M, Mokhtari M, Mohammad MM, Aslani J. Bronchiolitis obliterans following exposure to sulfur mustard: chest high resolution computed tomography. Eur J Radiol 2004; 52: 164-169 (Pubitemid 39361117)
82. Ghanei M, Moqadam FA, Mohammad MM, Aslani J. Tracheobronchomalacia and air trapping after mustard gas exposure. Am J Respir Crit Care Med 2006; 173: 304-309 (Pubitemid 43209085)
83. WHO. Chemical agents. In: Perry- Robinson JP, ed. Public Health Response to Biological and Chemical Weapons. 2nd ed. Geneva, Switzerland: World Health Organization; 2004. p. 164-701.
84. Bijani KH, Moghadamnia AA. Long-term effects of chemical weapons on respiratory Tract in the Iran-Iraq war victims living in Babol (North of Iran). Ecotoxicol Environ Safe 2002; 53: 422-424
85. Balali-Mood M, Hefazi M, Mahmoudi M, et al. Evaluation of delayed toxic effects of Sulfur mustard poisoning in severely intoxicated Iranian veterans. J Med CB R Def. 2005: 3. Available from: URL: http://www.J Med Chem Def.org/issue-0301/Balali-Mood-0405.html.
86. Ghanei M. Darvishzadeh F, Alaeddini I, et al. Accuracy of Impulse Oscillometry in Airway Dysfunction. Iran J Med Sci 2007; 32: 205-210. (Pubitemid 351270410)
87. Hosseini K, Bagheri MH, Alavi S. Development of bronchiectasis, a late sequel of mustard gas exposure. Iran J Med Sci 1998; 23: 81-84
88. Ghanei M, Akhlaghpoor A, Mohammad MM, Aslani J. Tracheobronchial stenosis following mustard gas inhalation. Inhal Toxicol 2004; 16: 845-849 (Pubitemid 39447340)
89. Aslani J. Late respiratory complications of sulfur mustard. In: Cheraghali AM, ed. Prevention and Treatment of Complications of Chemical Warfare Agents. Tehran, Iran: Chemical Warfare Research Center; 2000. p. 76-79
90. Sohrabpour H. Evaluation of late toxic effects of sulfur mustard poisoning with electron microscopy of lung biopsies. [dissertation]. Shaheed Beheshti University of Medical Sciences: Tehran, Iran; 1992.
91. Warthin AS, Weller CV. Diagnosis and treatment of lesions due to vesicants. Br Med J 1944; 2: 109-112
92. Fekri AR, Janghorbani M. Late cutaneous complications in Iranian veterans. The Seminar on Late Complications of Chemical Warfare Agents in Iranian Veterans. Tehran, Iran: Veteran Foundation; 1992. p. 57-89.
93. Khehr NW. Late manifestations in former mustard gas workers with special consideration of the cutaneous findings. Zeitschrift fur Hautkrankheiten 1984; 59: 1161-1170
94. Blodi FC. Mustard gas keratopathy. Int Ophthalmol Clin. 1971; 2: 1-13.
95. English F, Bennett Y. The challenge of mustard gas keratopathy. Med J Aust 1990, 152: 55-56
96. Hughes WF. Mustard gas injuries to the eyes. Arch Ophthalmol 1942; 27: 582-601.
97. Pleyer U, Sherif Z, Baatz H, Hartmann C. Delayed mustard gas keratopathy: clinical findings and confocal microscopy. Am J Ophthalmol 1999; 128: 506-507 (Pubitemid 29479327)
98. Javadi MA, Kazemi-Moghadam M. Ocular effects of sulfur mustard poisoning. In: Cheraghali AM, ed. Prevention and Treatment of Complications of Chemical Warfare Agents. Tehran, Iran: Chemical Warfare Research Center; 2000. p. 82-101.
99. Solberg Y, Alcalay M, Belkin M. Ocular injury by mustard gas. Surv Ophthalmol 1997; 41: 461-466
100. Tabatabaee SM. Study of psychiatric complications of poisoning with chemical warfare agents. The First International Medical Congress on Chemical Warfare Agents in Iran. June 13-6, Mashhad, Iran: Mashhad University of Medical Sciences, 1988. p. 66.
101. Hashemian F, Khoshnood K, Desai MM, et al. Anxiety, Depression and posttraumatic stress in Iranian survivors of chemical warfare. JAMA 2006; 296: 560-566 (Pubitemid 44157130)
102. Ludlum DB, Kent S, Mehta JR. Formation of O6- ethylthioethylguanine in DNA by reaction with the sulfur mustard, chloroethyl sulfide, and its apparent lack of repair by O6-alkylguanine-DNA alkyltransferase. Carcinogenesis 1986; 7: 1203-1206 (Pubitemid 17127480)
103. Takeshima Y, Inai K, Bennett WP, et al. p53 mutations in lung cancers from Japanese mustard gas workers. Carcinogenesis 1994; 15: 2075-2079 (Pubitemid 24317460)
104. Yanagida J, Hozawa S, Ishioka S, et al. Somatic mutation in peripheral lymphocytes of former workers at the Okunojima poison gas factory. Jpn J Cancer Res 1988; 79: 1276-1283 (Pubitemid 20019404)
105. Azizi F, Keshavarz A, Roshanzamir F, Nafarabadi M. Reproductive function in men following exposure to chemical warfare with sulfur mustard. Medicine and war 1995; 11: 34-44.
106. Gholamrezanezhad A, Saghari M, Vakili A, et al. Myocardial perfusion abnormalities in chemical warfare patients intoxicated with mustard gas. Int J Cardiovasc Imaging 2007; 23: 197-205. (Pubitemid 46431543)
107. Callaway S, Pearce KA. Protection against systemic poisoning by mustard gas, di(2- chloroethyl) sulphide, by sodium thiosulphate and thiocit in the albino rat. Br J Pharmacol Chemother 1958; 13: 395-398
108. Connors TA, Jeney A, Jones M. Reduction of the toxicity of 'radiomimetic'alkylating agents in rats by thiol pretreatment. The mechanism of the protective action of thiosulfate. Biochem Pharmacol 1964; 13: 1545-1550
109. Kehe K, Balszuweit F, Emmler J, et al. Sulfur mustard research-strategies for the development of improved medical therapy. Eplasty 2008; 8: e32.
110. Mérat S, Perez JP, Rüttimann M, et al. Acute poisoning by chemical warfare agent: sulfur mustard. Ann Fr Anesth Reanim 2003; 22: 108-118 (Pubitemid 36528367)
111. Panahi Y, Davoudi SM, Sadr SB, et al. Impact of pruritus on quality of life in sulfur mustard-exposed Iranian veterans. Int J Dermatol 2008; 47: 557-561 (Pubitemid 351676493)
112. Andrew DJ, Lindsay CD. Protection of human upper respiratory tract cell lines against sulphur mustard toxicity by hexamethylenetetramine (HMT). Hum Exp Toxicol 1998; 17: 373-379 (Pubitemid 28401189)